TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -75.0% | 3,000 | -66.7% | 0.00% | – |
Q3 2018 | $8,000 | 0.0% | 9,000 | 0.0% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 9,000 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | 0.0% | 9,000 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $7,000 | -12.5% | 9,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $8,000 | -11.1% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $9,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Arena Capital Advisors, LLC- CA | 68,443,000 | $68,785,000 | 10.97% |
PIPER SANDLER & CO. | 12,550,000 | $12,425,000 | 8.95% |
Radcliffe Capital Management, L.P. | 100,783,000 | $100,279,000 | 6.28% |
INCOME RESEARCH & MANAGEMENT | 14,775,000 | $14,701,000 | 5.39% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,123,000 | 1.30% |
Bracebridge Capital, LLC | 5,500,000 | $5,390,000 | 0.82% |
Western Asset Management Company, LLC | 9,000,000 | $8,916,000 | 0.57% |
WESTWOOD HOLDINGS GROUP INC | 43,125,000 | $42,856,000 | 0.49% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,050,000 | $1,045,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,675,000 | 0.35% |